The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.
The growth of the market is driven by the factors such as, growing geriatric population and rapid technological advancements in diabetes care devices. However, the diabetes care devices market is likely to get impacted due to high cost of diabetes care devices and risks associated with the insulin delivery devices in the region.
The pen needles attached to injection pens have been found to be re-used by the patients at a significant rate. One of the major reason behind this reuse is known to be the cost of these needles. Although the initial price of these pen needles are on a cheaper side, the existing prices are still a reason for lesser number of units sold as compared to the doses administered by patients on an average. According to a survey conducted by BD in determining the pattern of pen needle usage among population in 2014-2015, 23.3% participants in the survey reported reuse of pen needles due to the price of these needles as well as for cost-saving purposes. Thus, the market launch of affordable yet efficient pen needles is expected to be one of the potential opportunities that can be utilized by the market players to increase their sales and thereby establish a significant position in the highly competitive pen needles market. Few of the top companies have also started taking steps towards development and launch of such products in the market. For instance, in July 2017, Becton, Dickinson and Company (BD), as a part of action of the Health Service Medical Supplies Act 2017, launched Viva insulin pen needles as a cost effective option for people with diabetes to accommodate extreme budgetary pressure on the National Health Services (NHS). The company aimed to ensure presence of cost-effective options for high-quality pen needles in the UK. Various similar launches are expected to provide growth opportunities to emerging and local players in the global pen needles market.
US is expected to lead the market in the North America region owing to rise in the prevalence of the diabetes and growing elder population in the region. However, the country lags behind the other developed countries that can be a restrain to the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
Maxico Diabetes Care Devices Market Revenue and Forecasts to 2027 ( US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA DIABETES CARE DEVICES – MARKET SEGMENTATION
By Product
- Glucose Monitoring Devices
- Glucometers
- Lancets
- Testing Strips
- Other Glucose Monitoring Devices
- Insulin Delivery Devices
- Insulin Pens
- Insulin Syringes
- Insulin Pumps
- Other Insulin Delivery Devices
By End User
- Hospitals & Clinics
- Homecare
By Geography
North America
- US
- Canada
- Mexico
Company Profiles
- BD
- Novo Nordisk A/S
- B. Braun Melsungen AG
- Insulet Corporation
- Medtronic
- Tandem Diabetes Care, Inc.
- Eli Lilly and Company
- Dexcom, Inc.
- Terumo Corporation
- F. Hoffman-LA Roche Ltd.
North America Diabetes Care Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 8,936.5 Million |
Market Size by 2027 | US$ 15,300.0 Million |
Global CAGR (2019 - 2027) | 6.3% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - North America Diabetes Care Devices Market
- BD
- Novo Nordisk A/S
- B. Braun Melsungen AG
- Insulet Corporation
- Medtronic
- Tandem Diabetes Care, Inc.
- Eli Lilly and Company
- Dexcom, Inc.
- Terumo Corporation
- F. Hoffman-LA Roche Ltd.


